Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Cognitive Neuropsychiatry|November 30, 2010
Auditory false perceptions are mediated by psychosis risk factorsEmma Barkus, Richard Smallman, Natalie Royle, et al.Molecular Psychiatry|July 2, 2020
Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesisSilke Conen, Catherine J Gregory, Rainer Hinz, et al.Trials|July 22, 2022
REACH-ASD: a UK randomised controlled trial of a new post-diagnostic psycho-education and acceptance and commitment therapy programme against treatment-as-usual for improving the mental health and adjustment of caregivers of children recently diagnosed with autism spectrum disorderKathy Leadbitter, Richard Smallman, Kirsty James, et al.Autism : the International Journal of Research and Practice|September 18, 2024
The development, feasibility and acceptability of Empower-Autism: A new psychoeducational and psychotherapeutic programme for caregivers of children recently diagnosed with autismKathy Leadbitter, Louisa Harrison, Sophie Langhorne, et al.The Lancet. Psychiatry|March 14, 2025
Clinical effectiveness of an online psychoeducational and psychotherapeutic programme for caregivers of children newly diagnosed as autistic: a parallel, assessor-masked, randomised controlled trial in the UK (REACH-ASD)Kathy Leadbitter, Sophie Langhorne, Richard Smallman, et al.Eclinicalmedicine|November 3, 2025
A post-diagnostic psycho-education, acceptance and commitment therapy programme for caregivers of children recently diagnosed with autism: a randomised controlled trial-based cost-effectiveness analysis (REACH-ASD Trial)Gemma Shields, Aleix Rowlandson, Linda Davies, et al.Molecular Psychiatry|November 18, 2025
Investigating the disturbance in cortical glutamate and GABA function in psychosis and its origins and consequencesBill Deakin, Elizabeth Liddle, Mohanbabu Rathnaiah, et al.The Lancet. Psychiatry|October 17, 2018
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialBill Deakin, John Suckling, Thomas R E Barnes, et al.Pageof 1